Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 17, 2026

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

Individualized Biochemical Profiling in Drug Design: Integrating MultiOmics, Nanotechnology, and Machine Learning.

Rizwan Ahmad1, Sana Siddiqui1, Safia Habib1

  • 1Department of Biochemistry, Jawaharlal Nehru Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Current Pharmaceutical Biotechnology
|July 16, 2026
PubMed
Summary

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetics of Chronic Stress: Mechanisms and Health Impacts.

Current genomics·2026
Same author

Potential Involvement of Fructosylated Human Insulin and Serological Evidence in Subclinical Autoimmune Activity in Type 2 Diabetes Mellitus.

Current diabetes reviews·2026
Same author

Catalyst-Free Green Synthesis of Spirooxindole Pseudo-Natural Products With Anti-ROS and Cytoprotective Effects.

Chemistry & biodiversity·2026
Same author

Peroxynitrite-induced structural alterations render human fibrinogen more immunogenic: A possible mechanism of auto-immune response that acts as a proatherogenic marker.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

Leveraging RAS-mSIN1 interaction to selectively inhibit mTORC2 employing competitive RAS binding peptide: implications in breast cancer metastasis.

Oncogene·2025
Same author

Metformin Protects Human Insulin from Fructosylation: An <i>In Vitro</i> Biochemical Study.

Current medicinal chemistry·2025

Individualized biochemical profiles revolutionize drug development by considering personal variations. This personalized approach enhances drug efficacy, safety, and targeted delivery, moving beyond conventional methods for better patient outcomes.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Conventional drug development often overlooks inter-individual variability, leading to suboptimal efficacy and adverse reactions.
  • Personalized biochemical signatures, influenced by genomics, epigenetics, and microbiome interactions, significantly impact drug pharmacokinetics and pharmacodynamics.
  • Existing drug design models require re-evaluation due to the influence of these factors on absorption, distribution, metabolism, and excretion (ADME).

Purpose of the Study:

  • To explore the revolutionary potential of individualized biochemical profiling in modern medicinal chemistry.
  • To highlight how integrating metabolomics, targeted nanotechnology, and machine learning can refine drug development and clinical applications.
  • To discuss the impact of personalized biochemical data on predicting drug toxicity and enhancing drug delivery systems.
Keywords:
Personalized biochemical parametersdrug-induced liver injuryelectronic health recordhealthcare systemmulti-omicsnanocarrier-based drug deliveryprecision medicine

Related Experiment Videos

Last Updated: Jul 17, 2026

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

Main Methods:

  • A structured literature review of peer-reviewed studies from leading scientific databases.
  • Emphasis on recent and translationally relevant research in pharmacogenomics, high-throughput screening, and quantitative structure-activity relationship (QSAR) models.
  • Analysis of the combined impact of metabolomics, targeted nanotechnology, and machine learning in drug discovery.

Main Results:

  • Individualized biochemical profiling enables the development of drugs better suited to an individual's metabolic and enzymatic profiles.
  • This approach aids in predicting drug-induced liver injury (DILI) and other organ-specific toxicities, improving safety before clinical trials.
  • Personalized data enhances nanocarrier-based drug delivery systems for improved tissue targeting and reduced off-target effects.

Conclusions:

  • Individualized biochemical profiling, driven by pharmacogenomics, high-throughput screening, and QSAR, is transforming drug design.
  • The amalgamation of metabolomics, targeted nanotechnology, and machine learning holds significant potential to reshape clinical interventions.
  • Refining drug reactions at the individual level through personalized biochemical data promises improved therapeutic outcomes and enhanced patient safety.